Home
Novavax NVAX spent $130K on lobbying in Q2 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $130,000
- Quarter
- Q2 2026
- Stock
- Novavax NVAX
- Client
- Novavax
- Reported
- 26/07/17
Down 7.1% from last quarter
What else happened in Novavax around then
Filed or reported within 30 days of the trade day · 05/31~07/30Novavax's other lobbying reports
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 07/16
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 07/15
for Q2
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$140K
$140K
Reported 04/20
for Q1
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 04/16
for Q1
- Novavax
LobbyingNovavax
LobbyingNovavax
NVAX
$50K
$50K
Reported 04/15
for Q1